Objective-The genetic contribution to coronary artery disease (CAD) remains largely unclear. We combined genetic screening with functional characterizations to identify novel loci and candidate genes for CAD. ), associated with CAD with genome-wide significance. The risk allele of rs9486729 and protective allele of rs17165136 were associated with the decreased expression of their host genes, SCML4 and THSD7A, respectively, whereas rs852787 did not have transcriptional effects on any gene. Knockdown of SCML4 activated endothelial cells by increasing the expression of IL-6, E-selectin, and ICAM and weakened their antiapoptotic activity, whereas the knockdown of THSD7A had little effect on these endothelial cell functions but attenuated monocyte adhesion via decreasing the expression of ICAM, L-selectin, and ITGB2. We further showed that inhibiting the expression of SCML4 exacerbated endothelial dysfunction and vascular remodeling in a rat model with partial carotid ligation. Conclusions-We identify 3 novel loci associated with CAD and show that 2 genes, SCML4 and THSD7A, make functional contributions to atherosclerosis. How rs852787 and its host gene DAB1 are linked to CAD needs further studies. Visual Overview-An online visual overview is available for this article. (Arterioscler Thromb Vasc Biol. 2018;38: 964-975.
C oronary artery disease (CAD) is caused by the stenosis or occlusion of coronary arteries, mostly resulting from atherosclerotic lesions on the vascular wall.
1,2 Etiologically, aging, male sex, hypertension, and diabetes mellitus, as well as hyperlipidemia are risk factors. 3, 4 In addition, familial aggregation and an increased risk of CAD in first-degree relatives, particularly siblings, suggest that genetic components contribute to CAD as well. 5 Searching for genetic components is helpful for obtaining further insight into the pathogenesis of CAD. More importantly, identified genes can be used as markers for early prediction and as novel pharmacological targets for precise treatment of CAD. Mechanistically, emerging evidence supports the idea that endothelial cell survival, monocyte adhesion, and inflammation are critical for the formation of atherosclerotic plaques-the pathological feature on the coronary artery wall(s) in patients with CAD. 6 During the past decade, great efforts have been made to find candidate genes at the genome level using family-based linkage analyses and population-based association studies. This has led to the successful identification of dozens of genes and loci associated with CAD. 2, [7] [8] [9] [10] [11] On the contrary, genetic association studies face challenges. First, although >50 common single nucleotide polymorphisms (SNPs) reaching genome-wide significance (P<5×10 −8 ) have been identified in genome-wide association studies (GWAS) of whites, the majority of CAD heritability remains unexplained, 2, 9, 12, 13 indicating that other candidate genes may be important. Second, the environment and different genetic backgrounds may have strong effects on the genetic association with disease, so that many identified loci are population dependent. 7, 14 By far, the largest number of loci have been found in studies of white, and only 5 have been independently reported from GWAS in Han Chinese populations. 15, 16 Actually, the average genetic differences among Han Chinese populations are lower than those among people of European ancestry, 17 suggesting that genetic studies of Han Chinese populations may have a higher sensitivity in the discovery of susceptibility genes. Third, a considerable number of positive loci are localized in intergenic regions where our knowledge is relatively rudimentary. It is not known exactly which functional genes they regulate to link them to CAD, despite the proposal of several hypotheses. 15, 16, [18] [19] [20] Finally, because of the lack of mechanistic studies, it is difficult to translate the biological insights to clinical benefits.
Here, we combined GWAS with functional analyses to search for novel candidate genes for CAD. To achieve this, we first performed a multistage genetic association study in 8 Chinese cohorts to identity candidate loci and genes and then performed functional studies in vitro and in vivo to link these candidates to atherosclerosis that is fundamental to CAD.
Materials and Methods

Human Participants and Sampling
For human studies, all participants were recruited, and blood samples were collected correspondingly from 11 local hospitals in 5 geographic regions in China (Figure 1 . Written informed consent was received from participants before inclusion in this study. The study was conducted following the principles outlined in the Declaration of Helsinki and approved by the Institutional Review Board, Institute of Molecular Medicine, Peking University. The blood samples were kept at 4°C and transported to the Department of Human Population Genetics, Peking University, for DNA extraction.
CAD was defined by presentation of ≥1 of the following conditions: (1) existing myocardial infarction, (2) treated with percutaneous coronary intervention or a coronary artery bypass graft, and (3) >50% stenosis of at least 1 of the 3 major coronary arteries (left anterior descending, circumflex, or right coronary artery) demonstrated by coronary angiography. The controls were from the cohorts with at least a 5-year follow-up of general physical examination and were included when they geographically matched with cases and met all the following criteria: (1) no family history of CAD, (2) no clinical symptoms (angina, chest pressure, or shortness of breath) of CAD, and (3) normal morphology of the resting ECG. Those with stroke, peripheral vascular disease, congenital heart disease and kidney disease, or cancer were excluded. Hypertension and diabetes mellitus were diagnosed according to criteria described previously. 7 Triglyceride, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol were from their medical examination records.
Genotyping and Quality Control
The experimental design is shown in Figure 1 . The discovery stage involved genome-wide screening followed by replication in another population. For genome-wide screening, the samples were genotyped with For validation, the positive SNPs from above were further genotyped with TaqMan technology following the manufacturer's protocols in all remaining populations. Obscure genotypes (allelic discrimination not measurable automatically using Sequence Detection System 2.1 software) were dropped. To validate the TaqMan data, in each population, we randomly selected 96 samples for each SNP and genotyped them by direct Sanger sequencing. The cross-platform concordance was 100% for all SNPs, thereby confirming the accuracy of the genotyping.
Imputation
The software IMPUTE2 was used to impute genotypes for autosomal SNPs using the1000 Genomes Project Han Chinese in Beijing, China, and Japanese in Tokyo, Japan data (March 2012 release) as a reference. We included only SNPs with genotype call rates ≥0.95, no significant deviation from HWE (P≥5.00×10 −3 in controls), info score >0.5, and minor allele frequency ≥0.02.
Real-Time Polymerase Chain Reaction
Total RNA was extracted from human umbilical vein endothelial cells (HUVECs), human aorta smooth muscle cells, and human white blood cells, as well as human lung carcinoma cells, human colorectal carcinoma cells, human embryonic kidney cells, human cervical carcinoma cells, human liver carcinoma cells, human leukemia T cells, human breast cancer cells, human mononuclear cells, and human astroglioma cells using the TRIzol reagent method according to the kit manual (TRIzol Reagent; Invitrogen). Five micrograms of RNA was used for reverse transcription. Subsequently, polymerase chain reaction was performed with the primers listed in Table III in the online-only Data Supplement, and the products were visualized by loading onto 2% agarose gel followed by ethidium bromide staining.
Expression Quantitative Trait Locus Analyses
Three hundred young, healthy individuals were randomly recruited from a medical center in Beijing. The target SNPs were genotyped by direct Sanger sequencing. Based on the results of a genotypic association study, for rs9486729 and rs17165136, we divided the population into 2 groups based on the dominant (AA versus AG+GG, where G is the risk allele) and recessive (AA versus AG+GG, where A is the risk allele) genetic model, in which the 2 SNPs showed a stronger association with CAD. Sex, age, and body mass index were matched between the 2 groups. The total RNA of white blood cells was isolated and purified using the TRIzol reagent method described above. The amounts of target transcripts were quantified by real-time polymerase chain reaction. The primers used in expression quantitative trait locus (eQTL) analysis and in expression detection ( Figure 2) were the same.
Expression of Cytokines and Adhesion Molecules in HUVEC and Human Mononuclear Cell Lines by Real-Time Polymerase Chain Reaction
The expression of target genes was knocked down using the listed siRNA (Table IV in the online-only Data Supplement). Primers were designed (listed in Table V in the online-only Data Supplement), and real-time polymerase chain reaction was performed to assess gene expression. <1.0×10 −25 <1.0×10 −25 rOR and rP denote row ORs and P values calculated by logistic regression; aOR and aP, adjusted ORs and P values calculated by logistic regression with covariates age and sex. aOR indicates adjusted odds ratio; aP, adjusted P value; cOR, combined odds ratio; cP, combined P value; DAB1, disabled-1; NCBI, National Center for Biotechnology Information; RAF, risk allele frequency; rOR, row odds ratio; rP, row P value; SCLM4, Scm polycomb group protein-like 4; SNPs, single nucleotide polymorphisms; and THSD7A, thrombospondin type 1 domain-containing 7A.
*Cannot be validated. †ORs and P values of combined meta-analysis performed with fixed-effects and inverse-variance weighted meta-analysis using the inverse-variance test. ‡ORs and P values of combined meta-analysis performed with fixed effects and weighted numbers of samples using the Mantel-Haenszel test.
Endothelial Cell Apoptosis Assay
Apoptosis in HUVECs was determined by flow cytometry that detected Annexin V-FITC (fluorescein isothiocyanate) staining according to the instructions with the BD Biosciences Clontech kit. Briefly, cells were incubated for 18 hours without fetal calf serum. At the end of incubation, the cells were harvested by trypsinization followed by centrifugation and suspended in 300 μL binding buffer. Annexin V-FITC was added to the cell suspension at a final concentration of 1 μg/mL. After 15 minutes at room temperature in the dark, 5 μL propidium iodide (PI, 10 μg/mL in binding buffer) was added and incubated for another 5 minutes. The stained cells were analyzed immediately with a FACScan Flow Cytometer using the FL1 and FL2 channels.
Rat Partial Carotid Ligation Model and shRNA Adenoviral Infection
All animal experiments were performed in accordance with the National Institutes of Health guidelines, and the protocols were approved by the Animal Care and Use Committee of Peking University (IMM-Tian XL-03-2). All rats were maintained in a specific pathogen-free environment certified by the Association for Assessment and Accreditation of Laboratory Animal Care International. Ten-week-old male Sprague-Dawley rats were ligated as described previously. [21] [22] [23] Before the external carotid artery was ligated, shRNA adenovirus (Table VI in the online-only Data Supplement) generated by the Ad-easy system according to the manufacturer's protocol was injected into the injured region through the internal carotid artery and incubated for 20 minutes. 24 The detailed procedure is described in Figure  IX in the online-only Data Supplement. The knockdown efficiency of shRNA was tested using aortic endothelial cells isolated from rats (Figure X in the online-only Data Supplement). After 2 weeks, the carotid arteries were isolated and fixed in 4% paraformaldehyde. Serial sections from external and internal carotid arteries to the branch of common carotid artery were cut. When the 2 lumina merged into one, the first section was obtained. Then, 1 of every 20 sections was retained until 5 sections were collected. Thus, sections at same distances from the branch were selected for hematoxylin/eosin staining. 25 The cross-sectional area of the lumen for each animal was calculated as the mean of the 5 sections. The luminal areas were measured using ImageJ software (version 1.45 from http://imagej.nih.gov).
Statistics
At the discovery stage, principal component analysis, identity-bystate/identity-by-descent analysis, quantile-quantile plots, Manhattan plots, HWE, and the associations between CAD traits and SNPs tested in a basic allelic model were performed using PLINK (version 1.07) software. We used a basic allelic model (with 1 degree of freedom) to evaluate the association between SNPs and CAD in each individual population using binary logistic regression in SPSS, version 16.0. The P values and corresponding odds ratios (ORs), as well as 95% CIs with and without adjustment for age (onset of the first event for cases or time of recruitment for controls) and sex were computed for each SNP.
We calculated the combined association statistics using 2 methods: (1) fixed-effects inverse-variance weighted meta-analysis and (2) fixed-effects Mantel-Haenszel-weighted meta-analysis.
In addition, we analyzed the association in the dominant, additive (with 2 degrees of freedom), and recessive genetic models using binary logistic regression. The inheritance model was defined according to the CAD risk alleles. In the dominant model, individuals with 1 or 2 CAD risk alleles were classified as 1, and individuals with no CAD risk alleles were classified as 0. In the recessive model, only individuals with 2 CAD risk alleles were classified as 1, and individuals with 1 or no CAD risk alleles were classified as 0. In the additive model, individuals with 2 CAD risk alleles were classified as 2, individuals with 1 CAD risk allele were classified as 1, and individuals with no CAD risk alleles were classified as 0.
For each individual, a risk score was calculated by summing the number of risk alleles (0, 1, or 2) at each of the 4 SNPs multiplied by the OR of the SNP showed in the combined analysis in Table 1 16 . Samples with incomplete genotype information were not included in this analysis. Based on the risk scores, we divided the last 6 populations into 5 groups. We regarded group 3 as a control group, and each of the other groups was compared with it. ORs (with 95% CIs) for the In functional analyses, the Shapiro-Wilk test was used to evaluate the normal distribution of data. The data in Figure 2C were not valid for parametric tests; so we used nonparametric Mann-Whitney U tests. The data in Figures 3 through 5 and Figures VIII and X in the online-only Data Supplement passed the normality test, so the t test combined with Levene test or 1-way ANOVA combined with post hoc multiple comparisons between groups were used. For post hoc multiple comparisons, we used Fisher least significant difference method when they passed the homogeneity-of-variance test and Dunnett T3 method when they failed it.
The URLs for web-based analysis, databases, and tools used in this study are listed in URLs in the online-only Data Supplement.
Results
Populations and Clinical Information
Eight Han Chinese populations (including BJ301, HB, NECHLJ, BJFWZR, NCHBHN, ECJSZJ, CCHUB, and SCGD) from 5 geographically distinct regions in China, involving 21 828 participants, were used in this study (Figure 1 ). Several genetic results but not GWAS have been reported using the samples in HB, 24, 26 BJFWZR, 7 NECHLJ, 7, 26 and CCHUB. 27, 28 The detailed clinical information for each population is provided in Table 2 .
Identification of 3 Novel Loci for CAD
To search for CAD-associated loci at the genome level, we first genotyped ≈450 000 SNPs in 650 samples using the Affymetrix Genome-wide Human SNP Array 5.0. To compare our results with other published datasets at this stage, we performed imputation with reference to the 1000 Genomes Project Chinese Han in Beijing, China, and Japanese in Tokyo, Japan data (March 2012 release comprising 186 individuals). We included only SNPs with genotype call rates ≥0.95, no significant deviation from HWE (P≥5.00×10 −3 in controls), info score >0.5, and minor allele frequency ≥0.02. After filtering, 3 520 774 SNPs were included for further analysis. We investigated whether the previously reported CAD loci in both Chinese and non-Chinese populations were validated. First, 12q21.33 (rs7136259), previously reported in Chinese CAD, was validated ( Figure IV in the online-only Data Supplement; Table 3 ). Another SNP, rs72787964 (P=1.31×10 −4 ), differed by only 35 kb from the reported SNP rs2123536 at 2p24.1 ( Figure IV in the onlineonly Data Supplement). Thus, 2 of 5 positive loci previously reported from 2 independent GWASs on Chinese CAD were validated. 15, 16 In non-Chinese populations, 9 loci (at 1p13.3, 1p32.2, 3p24.3, 5q31.1, 6p21.31, 7q32.2, 9p21.3, 13q34 , and Table 3) .
A strict P value cutoff may lead to missing SNPs with modest effects on a trait, particularly when a small population is used in genome-wide screening. To include more potentially positive SNPs, we used a P value of 5×10 −3 as a threshold, representing a departure between the observed and the expected P values on the quantile-quantile plot as previously used by other groups. 29 With this criterion, 283 novel SNPs were selected for genotyping at the replication stage using the GoldenGate platform (a well-validated SNP rs1333049 at 9p21.3 was also included), representing 283 chromosomal loci. In the end, we identified 3 novel SNPs (rs852787, rs9486729, and rs17165136) and replicated rs1333049 for a positive association with CAD (Table 1 ) through a 2-stage discovery approach. A flowchart describing SNP selection is provided in Figure VI in the online-only Data Supplement.
We then genotyped these 4 SNPs in 6 additional geographically distinct populations ( ; Table 1 ). The regional plots were obtained with all genotyped and imputed SNPs within 500 kb flanking the index SNP ( Figure 6A through 6D). Detailed information for genotyping control in each population is listed in Table I in the online-only Data Supplement.
Accumulated Risk Score, Prevalence, and Age at Onset of CAD
Based on the ORs and number of risk alleles at each locus, we calculated a risk score for each genotyped individual in the 6 validation populations. Then the combined validation population was divided into 5 clusters based on risk scores. The proportion of CAD cases in each cluster significantly increased with the risk score ( Figure 6E ). More importantly, we detected a significant association between risk score and age at disease onset (P=2.59×10 −4 ; Figure 6F ), providing the additional evidence for a genetic contribution of the 4 target SNPs to CAD.
Inheritance Models of Susceptibility Alleles for CAD
To understand the inherited nature of SNPs, we assessed the association of the 3 newly identified index SNPs with CAD in dominant, additive, and recessive models. We found that, in addition to the additive model, rs17165136 was also significant in the recessive model, whereas the other SNPs were more significant in their associations with CAD in dominant model (Table II in 
Identification of Potential Candidate Genes
Ten genes in a 1-Mb region flanking each newly identified SNP were considered to be potential candidate genes (Figure 2A ). To further show which genes have a potential link with atherosclerosis, we determined the expression of candidate genes in various types of cells critical to atherosclerosis-HUVECs, human aorta smooth muscle cells, and monocytes (human mononuclear cells)-and found that, except for DAB1 (disabled-1), all the genes were expressed in at least 1 type of cells functionally associated with atherosclerosis.
Because the SNPs rs9486729 and rs17165136 were located in the 5′-untranslated region of SCML4 and intron 1 of THSD7A, we first performed eQTL analysis to determine whether the index SNPs, rs9486729 and rs17165136, have any effect on the transcription of their host genes. We found that the risk allele (G) of rs9486729 and the protective allele (G) of rs17165136 significantly inhibited the expression of their host genes, SCML4 (P=0.022) and THSD7A (P=0.028), respectively ( Figure 2C ). Thus, we prioritized these 2 genes for functional assessment. The eQTL effect of rs852787 on DAB1 was not experimentally tested because DAB1 is not expressed in human white blood cells. To determine whether rs852787 is an eQTL for any gene, we inspected 3 eQTL databases (GTEx Portal, seeQTL, and eQTL resources from the Gilad/Pritchard group) and found that it had no cis-eQTL effects. However, we found that rs9486729 and SNPs in linkage disequilibrium with it were eQTLs for SCML4, which fully supported our result. None of the index SNPs or SNPs in linkage disequilibrium with index SNPs was an eQTL for the other 7 genes flanking the newly identified SNPs. Thus, we did not consider these genes in the subsequent analysis.
We also evaluated whether risk factors for atherosclerosis and CAD have any transcriptional consequences for SCML4 and THSD7A. HUVECs were exposed to high glucose and oxidized low-density lipoprotein, and the expression of SCML4 and THSD7A was determined. We found that both risk factors inhibited the expression of SCML4, whereas high glucose induced the expression of THSD7A ( Figure VIII in the online-only Data Supplement). These support the genetic findings that the altered expression of the 2 genes (decreased for SCML4 and increased for THSD7A) is associated with the risk for CAD.
SCML4 and THSD7A Are Linked to Atherosclerotic Mechanisms
To investigate the functional contributions of SCML4 and THSD7A to CAD, we determined their effects on the key processes of atherosclerosis-monocyte-endothelial cell adhesion, endothelial cell survival and activation, and inflammation-by individual knockdown of these genes. The selected siRNAs sufficiently inhibited the expression of SCML4 and THSD7A ( Figure 3A and 3B) . We showed that the knockdown of SCML4 in HUVECs upregulated the expression of IL-6, E-selectin, and ICAM ( Figure 3C through 3E) and promoted the apoptosis of endothelial cells induced by serum deprivation (Figure 3F ), whereas the knockdown of THSD7A in human mononuclear cells suppressed the expression of adhesion molecules ( Figure 4) . Knockdown of THSD7A in HUVECs had little effect on endothelial functions ( Figure 3G through 3J) .
In Vivo Knockdown of SCML4 Exacerbates Endothelial Dysfunction and Vascular Remodeling
We established a partial carotid ligation model in which atherosclerosis is associated with endothelial dysfunction, based on the previous description [21] [22] [23] 30 using rats. Thus, only SCML4, which had strong effects on endothelial cell function, was selected and used to treat this model using adenovirusmediated shRNA knockdown. Two weeks after partial carotid ligation, hematoxylin/eosin staining demonstrated that the carotid arteries that had been infected with SCML4 shRNA had a significantly lower luminal section area compared with arteries infected with scrambled shRNA ( Figure 5 ).
Discussion
In this study, we identified 3 novel intragenic SNPs (genes), rs9486729 (SCML4), rs17165136 (THSD7A), and rs852787 (DAB1), associated with CAD by genome-wide screening and subsequent validation in multicenter cohorts. We demonstrated that SCML4 and THSD7A made functional contributions to processes critical for atherosclerosis (endothelial cell activation and survival, inflammation, and adhesion) and showed that decreased expression of SCML4 exacerbated endothelial dysfunction and vascular remodeling in a rat model. How rs852787 and its host gene DAB1 are linked to CAD remains unknown.
Our study combined genetic findings with functional assessment, leading to the identification of 2 novel susceptibility genes for CAD. First, to minimize the effect of small populations at the discovery stage and increase the sensitivity in finding positive SNPs, the following measures were taken: (1) we matched cases with controls for age, sex, and geographic region; (2) the cutoff for P value was less strict in this study to include more SNPs that were potentially linked to CAD, as decided at the point when the observed and the expected P values on the quantile-quantile plot started to separate 29 ; and (3) we selected a large number of index SNPs that were novel and covered all target blocks at the genome level for replication. Finally, we validated the positive SNPs in 6 additional populations. Based on such considerations, 3 intragenic SNPs (genes), rs9486729 (SCML4), rs17165136 (THSD7A), and rs852787 (DAB1), were found to be associated with CAD at the GWAS level (P<10 −8 ).
We then evaluated whether the previously reported CAD loci were validated at our genome-wide screening stage and found that 2 loci (rs7136259 and rs72787964) from Chinese 15, 16 and 9 (at 1p13.3, 1p32.2, 3p24.3, 5q31.1, 6p21.31, 7q32.2, 9p21.3, 13q34, and 15q24.2) from non-Chinese were validated to be positive. 16, [31] [32] [33] [34] [35] [36] We also inspected the genetic associations of our 4 index SNPs with CAD in CardiogramPlusC4D consortium and detected significant positive signal for the SNP rs1333049 in 9p21.3 (P=3.56×10 for rs852787, rs9486729, and rs17165136, respectively) to reach significant associations (P=0.05) with reasonable power (0.85), which are much larger than its actual sample size (n=≈80 000). Thus, these SNPs present weak genetic effects in whites than in Chinese.
In fact, reproducibility is problematic in genetic association studies, even in large-population-based studies with people of the same ethnicity. For instance, the SNPs rs10953541, rs4618210, rs2943634, and rs2706399 were found to be associated with CAD in large-population-based GWASs, but they were not validated by each other. 19, 31, 33, 34 The fundamental reason for this phenomenon is likely because of the fact that each genetic variant has only a modest effect on a complex trait. 37 The detection of such a genetic variant is strongly influenced , the genes and their orientations within the target regions; circles, genotyped SNPs; rectangles, imputed SNPs; filled colors, ranges of r 2 with the index SNP; and purple circles, index SNP in the discovery stage 1 (solid) and combined samples (opened). E, Genetic risk score is associated with CAD incidence. Based on the risk score, the 6 validation populations were divided into 5 groups (G1-G5). Solid squares (with error bars), odds ratios (ORs; with 95% CIs) for CAD in different groups compared with group 3 (middle), corresponding to the y axis on the (left); gray bars, percentage of cases in each group, corresponding to the right y axis. F, Genetic risk score is inversely correlated with mean age at onset of CAD. Solid squares, mean age at CAD onset in each group, corresponding to the left y axis. The P value for bivariate correlation tests of risk score and onset age was 2.59×10 −4 . Gray bars, sample number of each group, corresponding to y axis at (right).
by population size, stratification, environmental factors, and the strictness of statistical analyses. High-quality cohorts (minimized strata) and validations in multicentered cohorts are essential considerations for a successful association study. Meta-analysis, which increases the sample size of populations, is also helpful. However, meta-analysis is affected by experimental similarity and validity. 38 Ultimately, whether a genetic variant truly contributes to a trait needs functional support.
We prioritized 2 candidate genes, SCML4 and THSD7A, for functional analysis and showed that the risk allele of rs9486729 was associated with the decreased expression of SCML4. Functional analysis in vitro suggested that SCML4 is critical to endothelial cell activation and the integrity of endothelium and thus functionally involved in the process of atherosclerosis and CAD. To further demonstrate this, we characterized the vascular remodeling induced by endothelial dysfunction in the partial carotid ligation model and demonstrated that knockdown of SCML4 increased the luminal stenosis, providing direct evidence that SCML4 is a functional gene for CAD.
THSD7A has been associated with various diseases, such as venous thromboembolism 39 and low bone mineral density, 40 that are correlated with atherosclerosis, [41] [42] [43] [44] supporting an association of THSD7A with CAD. Here, we found that the protective allele of rs17165136 had a negative eQTL effect on THSD7A, whereas knockdown of THSD7A markedly decreased the expression of adhesion molecules in monocytes, suggesting that the decreased expression of THSD7A protects blood vessel against atherosclerosis by suppressing the adherence of monocytes to endothelial cells. Because THSD7A had little effect on endothelial cell activation and apoptosis, this gene was not tested in the partial carotid ligation model. Interestingly, we found that the SNP rs852787 in intron 2 of the DAB1 gene was significantly associated with CAD (P=2.02×10 −14 ). However, DAB1 mRNA is not detectable in atherosclerosis-related cells and is not altered in atherosclerotic vessels as we reported previously. 45 Functionally, it has been reported that DAB1 functions as a cytosolic adaptor for ApoER2 and VLDLR in the Reelin signal pathway in neurons 46 and is also involved in cross talk between the Reelin and vascular endothelial growth factor signaling pathways. 47 These observations imply that DAB1 is a potential CAD susceptibility gene with an intrinsic link to neuronal control, lipid metabolism, and vascular function. Otherwise, the association of rs852787 may be driven by a gene much further away.
Our study has several limitations. First, our initial discovery population was modest, which decreases the sensitivity in searching for variants that did not make large contributions to CAD. Second, our SNP coverage was relatively low compared with the high-density chips developed later. Although imputation was performed to increase the comparability, it is possible that we missed some loci. Third, our analysis focused mostly on common SNPs to avoid excessive false-positives. We, therefore, could not assess the association of rare variants with CAD. Finally, in functional analysis, we only focused on genes harboring the index SNPs and did not assess remote effects of these SNPs on other genes, which may also be functionally linked to CAD.
In conclusion, we identified 3 novel intragenic SNPs, rs9486729 (SCML4), rs17165136 (THSD7A), and rs852787 (DAB1), associated with CAD. Functional analysis suggested the functional links of SCML4 and THSD7A to atherosclerosis.
